Status report
Get it in writing
The official USPTO status record for ATHERSYS, serial 76585361, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
ATHERSYSSerial 76585361 · Principal Register
Live · Registered
Owner: ABT HOLDING COMPANY
Class 001 -
Class 042 - Scientific & Technology Services
Filed Apr 06, 2004
Registered Sep 26, 2006
The record shows that ATHERSYS is a live Principal Register trademark owned by ABT HOLDING COMPANY, a Delaware corporation, and it has been renewed as of Dec 1 2016. The registration covers two classes: Class 001 for specialized cells and artificial genetic material used in scientific, laboratory and medical research, and Class 042 for scientific and clinical research services related to developing genetically‑characterized cells, therapeutic and diagnostic compounds, drug‑modeling data and a related database. A similar name would raise the closest concern if it were used for any of those biotech‑research products or services, because the listed scope is fairly narrow and focused on genetic‑cell research and related data work. The record does not give the owner control over every possible use of the word “Athersys” in unrelated fields. The most recent meaningful event is the 10‑year Section 8/9 renewal on Dec 1 2016; no further dates are supplied. The prosecution history contains no oppositions, cancellations or court actions, so the supplied history shows no visible enforcement activity. I'd treat this as a meaningful concern if you plan to market anything in the same scientific‑cell or drug‑modeling arena under a similar name.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.